The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".
Jul 5, 2024
0
435
Researchers at Children's Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The ...
Jun 14, 2024
0
66
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced ...
Jun 12, 2024
0
82
Some women who experience menopause early—before age 40—have an increased risk of developing breast and ovarian cancer, according to research being presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, ...
Jun 3, 2024
0
34
Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, ...
May 28, 2024
0
37
There is a positive association between use of intimate care products, including genital talc, and ovarian cancer, according to a study published online May 15 in the Journal of Clinical Oncology.
May 22, 2024
0
33
Immunotherapies have revolutionized cancer treatment by harnessing the body's own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each individual patient, ...
May 16, 2024
0
40
In ovarian cancer, the abnormal expression of various metabolic enzymes in the metabolism of polyunsaturated fatty acids (PUFA) is involved in the development of tumors and immune regulation. Most ovarian cancer patients ...
Mar 14, 2024
0
25
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
45
Imec teamed up with the KU Leuven laboratory of tumor immunology and immunotherapy for the first clinical validation of its cell sorter chip technology. The chip successfully identified PD-1 positive T cells in the blood ...
Feb 2, 2024
0
37
